Image-Guided Brachytherapy for Cervical Cancer
This trial is testing whether magnetic resonance imaging-guided therapy (MRT) is a better treatment for gynecologic cancers than the routinely used CT scan.
- Cervical Cancer
- Vaginal Cancer
- Bladder Cancer
- Uterine Cancer
- Vulvar Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is this research project open to individuals aged fifty-five and above?
"This study only allows participants that are between 18 and 100 years old, as declared within the inclusion criteria."
What is the current enrollment size of this medical experiment?
"Indeed, clinicaltrials.gov displays that this trial is actively recruiting participants who fit the eligibility criteria. The trial was initially posted on December 15th 2016 and has recently been updated on October 11th 2022; 54 patients must be enrolled from 2 sites."
Is there an open call for participants in this trial?
"According to the clinicaltrials.gov database, this study is currently recruiting and has been since December 15th 2016. The information was most recently updated on October 11th 2022."
Would I be eligible to join this clinical trial?
"This research requires 54 patients aged 18 and over with vaginal cancers to participate. The set of criteria for these applicants is as follows: having exceeded the age of majority, being likely to survive more than 6 months, displaying a diagnosis-defined site/stage status, potentially receiving prior radiation or chemotherapy treatments depending on their doctor's judgement call and finally showcasing carcinomas within their urethra at the discretion of physicians involved in care."